Federation des caisses Desjardins du Quebec’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
Other funds holding VBIV
PA
GAI
Federation des caisses Desjardins du Quebec's VBIV Position: Q4 2021 in Review
Federation des caisses Desjardins du Quebec sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2021, closing a stake of 217 shares — an estimated $20.2K sold.
Federation des caisses Desjardins du Quebec first reported a position in VBIV in Q2 2017 and held it in 18 quarters. The position peaked at $21.8K in Q2 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q4 2021.
- Federation des caisses Desjardins du Quebec reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2021 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 217 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2021, an estimated $20.2K.
- Federation des caisses Desjardins du Quebec first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 18 quarters.
- Federation des caisses Desjardins du Quebec's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $21.8K in Q2 2021.
- 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2021.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2021, filed 30 Aug 2024.